Skip to main content

Myriam Heiman

NIH Rank #823
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6299408Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Neurosciences
  • OTHER BASIC SCIENCES
  • ENGINEERING (ALL TYPES)

NIH Funding · FY2024

Linked Award Amount
$6M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#823
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Myriam Heiman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Myriam Heiman as a PI. Multi-PI records show the full award amount for context.

  • 5U01DA053631-04U01
    Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
    $2.6M
    award amount
  • 5R01NS127187-04R01
    Identification of TDP-43 modifiers through single-cell transcriptional and epigenomic dissection of ALS and FTLD-MND
    $1.8M
    award amount
  • 5R01DA054584-03R01
    Single-Cell Dissection of Ensembles and Cell Types Mediating Opioid Action in the Rodent Brain
    $616.6K
    award amount
  • 5R35NS127327-03R35
    Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease
    $526.6K
    award amount
  • 5R33HL154252-04R33
    Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain
    $432.2K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Broad Institute, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #823
  7. 2024
    Entered Top 25% Nationally
    Ranked #823
  8. 2024
    Entered Top 10% Nationally
    Ranked #823
  9. 2024
    Entered Top 5% Nationally
    Ranked #823
  10. 2025
    $10M Cumulative Funding
  11. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  12. 2025
    R01 Grant Holder
  13. 2025
    Program/Center Grant Leader